Holen Sie sich die Stockscreener-App
9.61
10.84%
0.94
Schlusskurs vom Vortag:
$8.67
Offen:
$8.89
24-Stunden-Volumen:
8,574
Relative Volume:
0.37
Marktkapitalisierung:
$6.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.05M
KGV:
-4.4698
EPS:
-2.15
Netto-Cashflow:
$-17.78M
1W Leistung:
+3.33%
1M Leistung:
-19.72%
6M Leistung:
-94.50%
1J Leistung:
-92.18%
1-Tages-Spanne:
$8.89
$10.21
1-Wochen-Bereich:
$8.67
$10.21
52-Wochen-Spanne:
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corporation
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
9.61 | 5.68M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Envveno Medical Corporation Aktie (NVNO) Neueste Nachrichten
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Pal-Item
Fed Watch: Can enVVeno Medical Corporation maintain sales growthMarket Volume Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
enVVeno Medical Announces Reverse Stock Split - The Florida Times-Union
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com
Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette
Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Highs Report: Is enVVeno Medical Corporation trading at a discount2025 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
enVVeno Medical Executes One-for-35 Reverse Stock Split - TipRanks
EnVVeno Medical announces reverse stock split; shares down 20% - MSN
enVVeno Medical announces RSS - Medical Buyer
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Do Not Use - ocbj.com
enVVeno Medical Stock Set to Reverse Split on Tuesday, January 20th (NASDAQ:NVNO) - Defense World
enVVeno Medical announces 1-for-35 reverse stock split By Investing.com - Investing.com Nigeria
enVVeno Medical Approves 1-for-35 Reverse Stock Split, Reducing Shares to 655K - Intellectia AI
enVVeno Medical announces 1-for-35 reverse stock split - Investing.com
enVVeno Medical board approves 1-for-35 reverse stock split - TipRanks
What enVVeno's 1-for-35 reverse stock split means for shareholders in 2026 - Stock Titan
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):